Search: onr:"swepub:oai:DiVA.org:uu-264815" >
The Impact of Graft...
-
Urbano-Ispizua, AlvaroUniv Barcelona, Hosp Clin, IDIBAPS, Dept Hematol, Barcelona, Spain.;Inst Res Josep Carreras, Barcelona, Spain.
(author)
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen
- Article/chapterEnglish2015
Publisher, publication year, extent ...
-
Elsevier BV,2015
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-264815
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-264815URI
-
https://doi.org/10.1016/j.bbmt.2015.05.010DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:132039712URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
The purpose of this study was to analyze the impact of graft-versus-host disease (GVHD) on the relapse rate of different lymphoma subtypes after allogeneic hematopoietic cell transplantation (allo-HCT). Adult patients with a diagnosis of Hodgkin lymphoma, diffuse large B cell lymphoma, follicular lymphoma (FL), peripheral T cell lymphoma, or mantle cell lymphoma (MCL) undergoing HLA-identical sibling or unrelated donor hematopoietic cell transplantation between 1997 and 2009 were included. Two thousand six hundred eleven cases were included. A reduced-intensity conditioning (RIC) regimen was used in 62.8% of the transplantations. In a multivariate analysis of myeloablative cases (n = 970), neither acute (aGVHD) nor chronic GVHD (cGVHD) were significantly associated with a lower incidence of relapse/progression in any lymphoma subtype. In contrast, the analysis of RIC cases (n = 1641) showed that cGVHD was associated with a lower incidence of relapse/progression in FL (risk ratio [RR],.51; P = 3.049) and in MCL (RR,.41; P = .019). Patients with FL or MCL developing both aGVHD and cGVHD had the lowest risk of relapse (RR,.14; P = .007; and RR,.15; P = .0019, respectively). Of interest, the effect of GVHD on decreasing relapse was similar in patients with sensitive disease and chemoresistant disease. Unfortunately, both aGVHD and cGVHD had a deleterious effect on treatment-related mortality and overall survival (OS) in FL cases but did not affect treatment-related mortality, OS or PFS in MCL. This study reinforces the use of RIC allo-HCT as a platform for immunotherapy in FL and MCL patients.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Pavletic, Steven Z.NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.
(author)
-
Flowers, Mary E.Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA.
(author)
-
Klein, John P.Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA.
(author)
-
Zhang, Mei-JieMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA.
(author)
-
Carreras, JeanetteMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.
(author)
-
Montoto, SilviaBarts Hlth NHS Trust, St Bartholomews Hosp, Dept Haematooncol, London, England.
(author)
-
Perales, Miguel-AngelMem Sloan Kettering Canc Ctr, Dept Med, Bone Marrow Transplant Serv, New York, NY 10021 USA.
(author)
-
Aljurf, Mahmoud D.King Faisal Specialist Hosp Ctr & Res, Dept Oncol, Riyadh, Saudi Arabia.
(author)
-
Akpek, GoerguenBanner MD Anderson Canc Ctr, Hematol Oncol Sect, Gilbert, AZ USA.
(author)
-
Bredeson, Christopher N.Ottawa Hosp, Blood & Marrow Transplant Program, Ottawa, ON, Canada.;Ottawa Hosp, Res Inst, Ottawa, ON, Canada.
(author)
-
Costa, Luciano J.Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA.
(author)
-
Dandoy, ChristopherCincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.
(author)
-
Freytes, Cesar O.South Texas Vet Hlth Care Syst, San Antonio, TX USA.;Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
(author)
-
Fung, Henry C.Temple Hlth, Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA USA.
(author)
-
Gale, Robert PeterUniv London Imperial Coll Sci Technol & Med, Dept Med, Div Expt Med, Hematol Res Ctr, London, England.
(author)
-
Gibson, JohnRoyal Prince Alfred Hosp, Inst Haematol, Camperdown, NSW 2050, Australia.
(author)
-
Hamadani, MehdiMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.
(author)
-
Hayashi, Robert J.Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA.
(author)
-
Inamoto, YoshihiroFred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA.
(author)
-
Inwards, David J.Mayo Clin, Div Hematol, Rochester, MN USA.
(author)
-
Lazarus, Hillard M.Univ Hosp Case Med Ctr, Seidman Canc Ctr, Cleveland, OH USA.
(author)
-
Maloney, David G.Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA.
(author)
-
Martino, RodrigoHosp Santa Creu & Sant Pau, Div Hematol, Barcelona, Spain.
(author)
-
Munker, ReinholdLouisiana State Univ Hlth, Dept Internal Med, Div Hematol Oncol, Shreveport, LA USA.
(author)
-
Nishihori, TaigaUniv S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Med Oncol, Tampa, FL 33612 USA.
(author)
-
Olsson, Richard F.Karolinska Institutet,Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD),Karolinska Inst, Dept Lab Med, Div Therapeut Immunol, Stockholm, Sweden.(Swepub:uu)riols677
(author)
-
Rizzieri, David A.Duke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA.
(author)
-
Reshef, RanUniv Penn, Dept Med, Abramson Canc Ctr, Med Ctr, Philadelphia, PA 19104 USA.
(author)
-
Saad, AymanUniv Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA.
(author)
-
Savani, Bipin N.Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA.
(author)
-
Schouten, Harry C.Acad Ziekenhuis, Dept Hematol, Maastricht, Netherlands.
(author)
-
Smith, Sonali M.Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA.
(author)
-
Socie, GerardHop St Louis, Dept Hematol, Paris, France.
(author)
-
Wirk, BaldeepSUNY Stony Brook, Med Ctr, Dept Internal Med, Stony Brook, NY 11794 USA.
(author)
-
Yu, Lolie C.Louisiana State Univ, Med Ctr, Childrens Hosp, Div Hematol Oncol,Ctr Canc & Blood Disorders, New Orleans, LA USA.
(author)
-
Saber, WaelMed Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.
(author)
-
Univ Barcelona, Hosp Clin, IDIBAPS, Dept Hematol, Barcelona, Spain.;Inst Res Josep Carreras, Barcelona, Spain.NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.
(creator_code:org_t)
Related titles
-
In:Biology of blood and marrow transplantation: Elsevier BV21:10, s. 1746-17531083-87911523-6536
Internet link
Find in a library
To the university's database
- By the author/editor
-
Urbano-Ispizua, ...
-
Pavletic, Steven ...
-
Flowers, Mary E.
-
Klein, John P.
-
Zhang, Mei-Jie
-
Carreras, Jeanet ...
-
show more...
-
Montoto, Silvia
-
Perales, Miguel- ...
-
Aljurf, Mahmoud ...
-
Akpek, Goerguen
-
Bredeson, Christ ...
-
Costa, Luciano J ...
-
Dandoy, Christop ...
-
Freytes, Cesar O ...
-
Fung, Henry C.
-
Gale, Robert Pet ...
-
Gibson, John
-
Hamadani, Mehdi
-
Hayashi, Robert ...
-
Inamoto, Yoshihi ...
-
Inwards, David J ...
-
Lazarus, Hillard ...
-
Maloney, David G ...
-
Martino, Rodrigo
-
Munker, Reinhold
-
Nishihori, Taiga
-
Olsson, Richard ...
-
Rizzieri, David ...
-
Reshef, Ran
-
Saad, Ayman
-
Savani, Bipin N.
-
Schouten, Harry ...
-
Smith, Sonali M.
-
Socie, Gerard
-
Wirk, Baldeep
-
Yu, Lolie C.
-
Saber, Wael
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Hematology
- Articles in the publication
-
Biology of blood ...
- By the university
-
Uppsala University
-
Karolinska Institutet